These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11313767)

  • 1. A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom.
    Heath KE; Humphries SE; Middleton-Price H; Boxer M
    Eur J Hum Genet; 2001 Apr; 9(4):244-52. PubMed ID: 11313767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of familial hypercholesterolaemia in Western Australia.
    Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM
    Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
    Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
    Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis in a small cohort of New Zealand patients originating from the United Kingdom demonstrates genetic heterogeneity in familial hypercholesterolemia.
    Thiart R; Varret M; Lintott CJ; Scott RS; Loubser O; du Plessis L; de Villiers JN; Boileau C; Kotze MJ
    Mol Cell Probes; 2000 Oct; 14(5):299-304. PubMed ID: 11040093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation screening of the LDLR gene and ApoB gene in patients with a phenotype of familial hypercholesterolemia and normal values in a functional LDL receptor/apolipoprotein B assay.
    Nissen H; Lestavel S; Hansen TS; Luc G; Bruckert E; Clavey V
    Clin Genet; 1998 Jul; 54(1):79-82. PubMed ID: 9727746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex ARMS analysis to detect 13 common mutations in familial hypercholesterolaemia.
    Taylor A; Tabrah S; Wang D; Sozen M; Duxbury N; Whittall R; Humphries SE; Norbury G
    Clin Genet; 2007 Jun; 71(6):561-8. PubMed ID: 17539906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mutations in patients with possible familial hypercholesterolaemia in South East Scotland.
    Ho CK; Stirling D; Hannant W; Walker SW
    Scott Med J; 2012 Aug; 57(3):148-51. PubMed ID: 22859806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
    Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.
    Ejarque I; Real JT; Martinez-Hervas S; Chaves FJ; Blesa S; Garcia-Garcia AB; Millan E; Ascaso JF; Carmena R
    Transl Res; 2008 Mar; 151(3):162-7. PubMed ID: 18279815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of Scotland.
    Lee WK; Haddad L; Macleod MJ; Dorrance AM; Wilson DJ; Gaffney D; Dominiczak MH; Packard CJ; Day IN; Humphries SE; Dominiczak AF
    J Med Genet; 1998 Jul; 35(7):573-8. PubMed ID: 9678702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of familial hypercholesterolaemia in Norway.
    Leren TP; Tonstad S; Gundersen KE; Bakken KS; Rødningen OK; Sundvold H; Ose L; Berg K
    J Intern Med; 1997 Mar; 241(3):185-94. PubMed ID: 9104431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
    Dedoussis GV; Skoumas J; Pitsavos C; Choumerianou DM; Genschel J; Schmidt H; Stefanadis C
    Eur J Clin Invest; 2004 Jun; 34(6):402-9. PubMed ID: 15200491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia.
    Dušková L; Kopečková L; Jansová E; Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2011 May; 216(1):139-45. PubMed ID: 21310417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DNA analysis in heterozygotes in familial hypercholesterolemia].
    Horínek A; Slézka V; Sobra J; Ceska R
    Cas Lek Cesk; 1995 Apr; 134(8):234-9. PubMed ID: 7758080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monogenic primary hypercholesterolaemia in South Africa.
    Rubinsztein DC; van der Westhuyzen DR; Coetzee GA
    S Afr Med J; 1994 Jun; 84(6):339-44. PubMed ID: 7740380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate.
    Graham CA; McIlhatton BP; Kirk CW; Beattie ED; Lyttle K; Hart P; Neely RD; Young IS; Nicholls DP
    Atherosclerosis; 2005 Oct; 182(2):331-40. PubMed ID: 16159606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations.
    Martin R; Latten M; Hart P; Murray H; Bailie DA; Crockard M; Lamont J; Fitzgerald P; Graham CA
    Atherosclerosis; 2016 Nov; 254():8-13. PubMed ID: 27680772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.